Basic Information
| RNALocate ID: | RLID:11002831 |
| RNA Symbol: | hsa-miR-451a |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-451a |
| RNA ID: | miRBase:MIMAT0001631 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25242326 |
| Tissue/Cell Line: | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells |
| Method: | Next-generation RNA sequencing |
| Description: | Although the miRNA distribution in exosomal fractions is clearly influenced by cellular miRNA abundance, we identified a subset of miRNAs that were discordantly distributed between cells and exosomes (false discovery rate [FDR] < 0.05; Tables S1B and S1C). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002818 | Exosome | Primary T lymphocytes | 24356509 |
| RLID:11002819 | Exosome | Plasma | 29130611 |
| RLID:11002820 | Exosome | Peripheral blood|Portal vein blood | 30561106 |
| RLID:11002821 | Exosome | Serum | 18589210 |
| RLID:11002822 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002823 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11002824 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11002825 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002826 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
| RLID:11002827 | Exosome | Brain tissue | 23382797 |
| RLID:11002828 | Exosome | Plasma | 23663360 |
| RLID:11002829 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002830 | Exosome | Plasma | 24130905 |
| RLID:11002832 | Extracellular Vesicle | Liposarcoma cell lines (Lipo224B|Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
| RLID:11002833 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002834 | Extracellular vesicle | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11002835 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002836 | Microvesicle | Liver resident stem cells|Mesenchymal stem cells | 20668554 |
| RLID:11002837 | Microvesicle | Plasma | 23077538 |
| RLID-D:11000144 | Exosome | Blood|B lymphoblastoid cells|Endothelial cells|Lymphoma tissue|Mast cells | |
| RLID-D:11000461 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-mir-451a | Pterygium | MNDR-E-MI-51116 |
| MNDR | hsa-mir-451a | Adult T cell leukemia | MNDR-E-MI-51117 |
| MNDR | hsa-miR-451a | Large cell neuroendocrine cancer | MNDR-E-MI-51118 |
| MNDR | hsa-miR-451a | Follicular lymphoma | MNDR-E-MI-51119 |
| MNDR | hsa-miR-451a | Medulloblastoma | MNDR-E-MI-51120 |
| MNDR | hsa-miR-451a | High-grade serous ovarian carcinoma | MNDR-E-MI-51121 |
| MNDR | hsa-miR-451a | Ovarian clear cell carcinoma | MNDR-E-MI-51122 |
| MNDR | hsa-miR-451a | Uterine corpus endometrial carcinoma | MNDR-E-MI-51123 |
| MNDR | hsa-miR-451a | Lymphoma | MNDR-E-MI-51124 |
| MNDR | hsa-miR-451a | Estrogen-receptor positive breast cancer | MNDR-E-MI-51125 |
| MNDR | hsa-miR-451a | Estrogen-receptor negative breast cancer | MNDR-E-MI-51126 |
| MNDR | hsa-miR-451a | Progesterone-receptor positive breast cancer | MNDR-E-MI-51127 |
| MNDR | hsa-miR-451a | Progesterone-receptor negative breast cancer | MNDR-E-MI-51128 |
| MNDR | hsa-miR-451a | Her2-receptor positive breast cancer | MNDR-E-MI-51129 |
| MNDR | hsa-miR-451a | Breast cancer luminal | MNDR-E-MI-51130 |
| MNDR | hsa-miR-451a | Anencephaly | MNDR-E-MI-51131 |
| MNDR | hsa-miR-451a | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-51132 |
| MNDR | hsa-mir-451a | Colorectal carcinoma | MNDR-E-MI-51133 |
| MNDR | hsa-miR-451a | Fatty liver non-alcoholic | MNDR-E-MI-51134 |
| MNDR | hsa-mir-451a | Fatty liver non-alcoholic | MNDR-E-MI-51135 |
| MNDR | hsa-mir-451a | Acth-independent macronodular adrenal hyperplasia; aimah | MNDR-E-MI-51136 |
| MNDR | hsa-miR-451a | Prostate cancer | MNDR-E-MI-51137 |
| MNDR | hsa-mir-451a | Early-stage gastric carcinoma | MNDR-E-MI-51138 |
| MNDR | hsa-miR-451a | Gastric cancer | MNDR-E-MI-51139 |
| MNDR | hsa-miR-451a | Alzheimer disease | MNDR-E-MI-51140 |
| MNDR | hsa-miR-451a | Sickle cell anemia | MNDR-E-MI-51141 |
| MNDR | hsa-mir-451a | Sickle cell diseases | MNDR-E-MI-51142 |
| MNDR | hsa-miR-451a | Intracranial aneurysm | MNDR-E-MI-51143 |
| MNDR | hsa-mir-451a | Bladder cancer | MNDR-E-MI-51144 |
| MNDR | hsa-miR-451a | Esophageal carcinoma | MNDR-E-MI-51145 |
| MNDR | hsa-mir-451a | Esophageal carcinoma | MNDR-E-MI-51146 |
| MNDR | hsa-miR-451a | Sarcoma | MNDR-E-MI-51147 |
| MNDR | hsa-miR-451a | Dysautonomia familial | MNDR-E-MI-51148 |
| MNDR | hsa-miR-451a | Seizures | MNDR-E-MI-51149 |
| MNDR | hsa-miR-451a | Head and neck cancer | MNDR-E-MI-51150 |
| MNDR | hsa-miR-451a | Hypertrophic cardiomyopathy | MNDR-E-MI-51151 |
| MNDR | hsa-miR-451a | Primary biliary cirrhosis | MNDR-E-MI-51152 |
| MNDR | hsa-miR-451a | Malaria | MNDR-E-MI-51153 |
| MNDR | hsa-mir-451a | Malaria | MNDR-E-MI-51154 |
| MNDR | hsa-miR-451a | Leukemia | MNDR-E-MI-51155 |
| MNDR | hsa-mir-451a | Leiomyoma | MNDR-E-MI-51156 |
| MNDR | hsa-miR-451a | Huntington disease | MNDR-E-MI-51157 |
| MNDR | hsa-miR-451a | Chorea | MNDR-E-MI-51158 |
| MNDR | hsa-miR-451a | Cardiovascular disease | MNDR-E-MI-51159 |
| MNDR | hsa-mir-451a | Dilated cardiomyopathy | MNDR-E-MI-51160 |
| MNDR | hsa-miR-451a | Moyamoya disease | MNDR-E-MI-51161 |
| MNDR | hsa-miR-451a | Brain cancer | MNDR-E-MI-51162 |
| MNDR | hsa-miR-451a | Uterine fibroid | MNDR-E-MI-51163 |
| MNDR | hsa-mir-451a | Lung cancer | MNDR-E-MI-51164 |
| MNDR | hsa-miR-451a | Lung cancer | MNDR-E-MI-51165 |
| MNDR | hsa-miR-451a | Down syndrome | MNDR-E-MI-51166 |
| MNDR | hsa-miR-451a | Parkinson disease | MNDR-E-MI-51167 |
| MNDR | hsa-miR-451a | Major depressive disorder | MNDR-E-MI-51168 |
| MNDR | hsa-miR-451a | Basal-like breast cancer | MNDR-E-MI-51169 |
| MNDR | hsa-mir-451a | Breast cancer | MNDR-E-MI-51170 |
| MNDR | hsa-mir-451a | Neoplasms | MNDR-E-MI-51171 |
| MNDR | hsa-mir-451a | Squamous cell carcinoma | MNDR-E-MI-51172 |
| MNDR | hsa-miR-451a | Thyroid cancer | MNDR-E-MI-51173 |
| MNDR | hsa-miR-451a | Pituitary neoplasms | MNDR-E-MI-51174 |
| MNDR | hsa-mir-451a | Pancreatic cancer | MNDR-E-MI-51175 |
| MNDR | hsa-miR-451a | Pancreatic cancer | MNDR-E-MI-51176 |
| MNDR | hsa-mir-451a | Supravalvar aortic stenosis | MNDR-E-MI-51177 |
| MNDR | hsa-miR-451a | Rectum adenocarcinoma | MNDR-E-MI-51178 |
| MNDR | hsa-miR-451a | Nephroblastoma | MNDR-E-MI-51179 |
| MNDR | hsa-miR-451a | Colon cancer | MNDR-E-MI-51180 |
| MNDR | hsa-mir-451a | Colon cancer | MNDR-E-MI-51181 |
| MNDR | hsa-miR-451a | Ischemic attack transient | MNDR-E-MI-51182 |
| MNDR | hsa-miR-451a | Colon adenocarcinoma | MNDR-E-MI-51183 |
| MNDR | hsa-miR-451a | Multiple sclerosis relapsing-remitting | MNDR-E-MI-51184 |
| MNDR | hsa-miR-451a | Familial ovarian cancer | MNDR-E-MI-51185 |
| MNDR | hsa-mir-451a | Ovarian cancer | MNDR-E-MI-51186 |
| MNDR | hsa-mir-451a | Basal cell carcinoma | MNDR-E-MI-51187 |
| MNDR | hsa-miR-451a | Prostate adenocarcinoma | MNDR-E-MI-51188 |
| MNDR | hsa-miR-451a | Thyroid adenomas | MNDR-E-MI-51189 |
| MNDR | hsa-mir-451a | Pulmonary tuberculosis | MNDR-E-MI-51190 |
| MNDR | hsa-miR-451a | Carcinoma ductal breast | MNDR-E-MI-51191 |
| MNDR | hsa-miR-451a | Glioblastoma | MNDR-E-MI-51192 |
| MNDR | hsa-mir-451a | Glioblastoma | MNDR-E-MI-51193 |
| MNDR | hsa-mir-451a | Glioblastoma multiforme somatic | MNDR-E-MI-51194 |
| MNDR | hsa-miR-451a | Glioma | MNDR-E-MI-51195 |
| MNDR | hsa-mir-451a | Glioma | MNDR-E-MI-51196 |
| MNDR | hsa-miR-451a | Chronic obstructive pulmonary disease | MNDR-E-MI-51197 |
| MNDR | hsa-mir-451a | Gastrointestinal neoplasms | MNDR-E-MI-51198 |
| MNDR | hsa-miR-451a | Amyotrophic lateral sclerosis | MNDR-E-MI-51199 |
| MNDR | hsa-miR-451a | Epilepsy temporal lobe | MNDR-E-MI-51200 |
| MNDR | hsa-miR-451a | Osteosarcoma | MNDR-E-MI-51201 |
| MNDR | hsa-mir-451a | Osteosarcoma | MNDR-E-MI-51202 |
| MNDR | hsa-miR-451a | Liposarcoma | MNDR-E-MI-51203 |
| MNDR | hsa-mir-451a | Liposarcoma | MNDR-E-MI-51204 |
| MNDR | hsa-miR-451a | Breast carcinoma | MNDR-E-MI-51205 |
| MNDR | hsa-miR-451a | Meningioma | MNDR-E-MI-51206 |
| MNDR | hsa-miR-451a | Liver cancer | MNDR-E-MI-51207 |
| MNDR | hsa-mir-451a | Mucinous cystadenocarcinoma | MNDR-E-MI-51208 |
| MNDR | hsa-miR-451a | Cervical adenocarcinoma | MNDR-E-MI-51209 |
| MNDR | hsa-miR-451a | Gastric adenocarcinoma | MNDR-E-MI-51210 |
| MNDR | hsa-miR-451a | Cervical squamous cell carcinoma | MNDR-E-MI-51211 |
| MNDR | hsa-miR-451a | Pituitary adenoma | MNDR-E-MI-51212 |
| MNDR | hsa-miR-451a | Lung squamous cell carcinoma | MNDR-E-MI-51213 |
| MNDR | hsa-mir-451a | Carcinoma lung non-small-cell | MNDR-E-MI-51214 |
| MNDR | hsa-miR-451a | Non-small cell lung cancer | MNDR-E-MI-51215 |
| MNDR | hsa-miR-451a | Lung adenocarcinoma | MNDR-E-MI-51216 |
| MNDR | hsa-mir-451a | Lung adenocarcinoma | MNDR-E-MI-51217 |
| MNDR | hsa-miR-451a | Thyroid carcinoma | MNDR-E-MI-51218 |
| MNDR | hsa-mir-451a | Papillary thyroid carcinoma | MNDR-E-MI-51219 |
| MNDR | hsa-miR-451a | Ovarian carcinoma | MNDR-E-MI-51220 |
| MNDR | hsa-miR-451a | Bladder urothelial carcinoma | MNDR-E-MI-51221 |
| MNDR | hsa-miR-451a | Pancreatic adenocarcinoma | MNDR-E-MI-51222 |
| MNDR | hsa-mir-451a | Cervical cancer | MNDR-E-MI-51223 |
| MNDR | hsa-miR-451a | Myasthenia gravis autoimmune experimental | MNDR-E-MI-51224 |
| MNDR | hsa-miR-451a | Carcinoma renal cell | MNDR-E-MI-51225 |
| MNDR | hsa-mir-451a | Renal cell carcinoma | MNDR-E-MI-51226 |
| MNDR | hsa-miR-451a | Kidney renal papillary cell carcinoma | MNDR-E-MI-51227 |
| MNDR | hsa-miR-451a | Renal clear cell carcinoma | MNDR-E-MI-51228 |
| MNDR | hsa-miR-451a | Large cell carcinoma | MNDR-E-MI-51229 |
| MNDR | hsa-miR-451a | Biliary tract cancer | MNDR-E-MI-51230 |
| MNDR | hsa-miR-451a | Intrahepatic cholangiocarcinoma | MNDR-E-MI-51231 |
| MNDR | hsa-miR-451a | Cholangiocarcinoma | MNDR-E-MI-51232 |
| MNDR | hsa-mir-451a | Esophageal cancer | MNDR-E-MI-51233 |
| MNDR | hsa-miR-451a | Esophageal cancer | MNDR-E-MI-51234 |
| MNDR | hsa-miR-451a | Liver cirrhosis | MNDR-E-MI-51235 |
| MNDR | hsa-miR-451a | Prolactinoma | MNDR-E-MI-51236 |
| MNDR | hsa-miR-451a | Lung small cell carcinoma | MNDR-E-MI-51237 |
| MNDR | hsa-miR-451a | Head and neck squamous cell carcinoma | MNDR-E-MI-51238 |
| MNDR | hsa-mir-451a | Head and neck squamous cell carcinoma | MNDR-E-MI-51239 |
| MNDR | hsa-mir-451a | Myocardial infarction | MNDR-E-MI-51240 |
| MNDR | hsa-miR-451a | Fibromyalgia | MNDR-E-MI-51241 |
| MNDR | hsa-mir-451a | Pulmonary hypertension | MNDR-E-MI-51242 |
| MNDR | hsa-miR-451a | Adenoma | MNDR-E-MI-51243 |
| MNDR | hsa-miR-451a | Breast invasive carcinoma | MNDR-E-MI-51244 |
| MNDR | hsa-mir-451a | Carcinoma hepatocellular | MNDR-E-MI-51245 |
| MNDR | hsa-miR-451a | Early hepatocellular carcinoma | MNDR-E-MI-51246 |
| MNDR | hsa-miR-451a | Embryonal cancer | MNDR-E-MI-51247 |
| MNDR | hsa-miR-451a | Familiar ovarian carcinoma | MNDR-E-MI-51248 |
| MNDR | hsa-mir-451a | Precursor b-cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-51249 |
| MNDR | hsa-miR-451a | B-cell lymphoma | MNDR-E-MI-51250 |
| MNDR | hsa-mir-451a | Rheumatoid arthritis | MNDR-E-MI-51251 |
| MNDR | hsa-miR-451a | Rheumatoid arthritis | MNDR-E-MI-51252 |
| MNDR | hsa-mir-451a | Hypopharyngeal cancer | MNDR-E-MI-51253 |
| MNDR | hsa-mir-451a | Gastroesphageal reflux | MNDR-E-MI-51254 |
| MNDR | hsa-miR-451a | Chronic myelogenous leukemia | MNDR-E-MI-51255 |
| MNDR | hsa-mir-451a | Chronic myelogenous leukemia | MNDR-E-MI-51256 |
| MNDR | hsa-miR-451a | Neuromyelitis optica | MNDR-E-MI-51257 |
| MNDR | hsa-mir-451a | Polycythemia vera | MNDR-E-MI-51258 |
| MNDR | hsa-miR-451a | Acute myelocytic leukemia | MNDR-E-MI-51259 |
| MNDR | hsa-mir-451a | Acute myeloid leukemia | MNDR-E-MI-51260 |
| MNDR | hsa-miR-451a | Colorectal cancer | MNDR-E-MI-51261 |
| MNDR | hsa-mir-451a | Colorectal cancer | MNDR-E-MI-51262 |
| MNDR | hsa-mir-451a | Carcinoma nasopharyngeal | MNDR-E-MI-51263 |
| MNDR | hsa-mir-451a | Nasopharynx carcinoma | MNDR-E-MI-51264 |
| MNDR | hsa-miR-451a | Tyrosinemias | MNDR-E-MI-51265 |
| MNDR | hsa-miR-451a | Leukemia lymphoblastic acute | MNDR-E-MI-51266 |
| MNDR | hsa-mir-451a | Diabetic nephropathies | MNDR-E-MI-51267 |
| MNDR | hsa-miR-451a | Ependymoma | MNDR-E-MI-51268 |
| MNDR | hsa-mir-451a | Erythropoiesis | MNDR-E-MI-51269 |
| MNDR | hsa-miR-451a | Hearing loss noise-induced | MNDR-E-MI-51270 |
| MNDR | hsa-miR-451a | Cardiomegaly | MNDR-E-MI-51271 |
| MNDR | hsa-mir-451a | Infection | MNDR-E-MI-51272 |
| MNDR | hsa-miR-451a | Nasopharyngeal cancer | MNDR-E-MI-51273 |
| MNDR | hsa-mir-451a | Trophoblasts | MNDR-E-MI-51274 |
| MNDR | hsa-mir-451a | Retinal neovascularization | MNDR-E-MI-51275 |
| MNDR | hsa-mir-451a | Ischemic heart disease | MNDR-E-MI-51276 |
| MNDR | hsa-miR-451a | Subarachnoid hemorrhage traumatic | MNDR-E-MI-51277 |
| MNDR | hsa-miR-451a | Stroke lacunar | MNDR-E-MI-51278 |
| MNDR | hsa-mir-451a | Non-alcoholic fatty liver disease | MNDR-E-MI-51279 |
| MNDR | hsa-miR-451a | Breast cancer her3+ negative | MNDR-E-MI-51280 |
| MNDR | hsa-miR-451a | High grade dysplastic nodule | MNDR-E-MI-51281 |
| MNDR | hsa-mir-451a | Hypopharyngeal squamous cell carcinoma | MNDR-E-MI-51282 |
| MNDR | hsa-mir-451a | Stroke susceptibility | MNDR-E-MI-51283 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022787 |
TOP